Global Obsessive Compulsive Disorder (OCD) Drugs Market is growing with 9.7% in the Forecast Period of 2021 to 2028

Global Obsessive Compulsive Disorder (OCD) Drugs Market is growing with factors such as rise in clinical trials, increasing cases of OCD globally, increasing R&D investments by key players, changes in lifestyle, and environmental stress among people.

Increasing generic approvals has propelled the demand of the market. However, unawareness among people of existence of OCD.

Global a market Scenario                                                       

According to Data Bridge Market Research, the market for obsessive compulsive disorder (OCD) drugs globally is growing with Market leader such as Sun pharmaceutical Industries Limited which accounts an estimated market share of approximately 9.23% .The Company has gained outstanding sale by providing obsessive compulsive disorder (OCD) drugs.   

  • In June 2021, Sun Pharmaceutical Industries Limited announced that one of its wholly owned subsidiaries has entered into a license agreement with Ferring Pharmaceuticals Pvt. Ltd. (Ferring), a subsidiary of Switzerland-based biopharmaceuticals MNC Ferring Pharmaceuticals, to commercialize a Room Temperature Stable (RTS) formulation of obstetric drug, CARITEC (Carbetocin RTS) in India. As per agreement terms, Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name CARITEC. Ferring has developed the drug and received approval from the Drugs Controller General of India (DCGI) for introducing the drug in India.

  Obsessive Compulsive Disorder (OCD) Drugs MarketTrends Impacting the Market

The global obsessive compulsive disorder (OCD) drugs market is becoming more competitive every year with companies like H.Lunderbeck A/S, Teva Pharmaceuticals USA, Inc (a subsidiary of Teva pharmaceutical Industries Ltd), Eli Lilly and Company, Apotex Inc, Viatris Inc, Lannett, GlaxoSmithKline Plc among others which are the market leaders for obsessive compulsive disorder (OCD) drugs.

The data bridge market research new reports highlight the major growth factors and opportunities in the global obsessive compulsive disorder (OCD) drugs market.        

For more analysis on the global obsessive compulsive disorder (OCD) drugs market request for a briefing with our analysts

New market Developments in 2021

  • In March 2021, Mallinckrodt plc, a global biopharmaceutical company, announced that its Specialty Generics division has been recognized as Manufacturing Leadership Award winners for outstanding achievement in two categories – Collaborative Innovation Leadership and Operational Excellence Leadership – by the National Association of Manufacturers (NAM).

In May, Viatris Inc. released its inaugural sustainability report, reinforcing its strong foundation in corporate social responsibility and commitment to doing its part to address some of the world's most pressing health needs by providing sustainable access to high-quality medicine, regardless of geography or circumstance.  The report provides a comprehensive, enterprise-wide overview of Viatris' operations as they relate to environmental, social and governance (ESG) matters and outlines efforts from the past year across five key areas of impact: patient health, employee health, environmental health, global public health and community health. It had helped to company to create a better picture for the future.

Scope of global analytical laboratory services

All country based analysis of global obsessive compulsive disorder (OCD) drugs market is further analyzed based on maximum granularity into further segmentation. On the basis of severity, global obsessive compulsive disorder (OCD) drugs market is segmented into mild to moderate, moderate to severe. On the basis of sub-type, global obsessive compulsive disorder (OCD) drugs market is segmented into contamination obsessions with washing/ cleaning compulsion, harm obsessions with checking compulsions,  obsessions without visible compulsions, symmetry obsessions with ordering, arranging, and, counting compulsions, hoarding, others. On the basis of route of administration, global obsessive compulsive disorder (OCD) drugs market is segmented into oral, parenteral.On the basis of population, global obsessive compulsive disorder (OCD) drugs market is segmented into paediatric, adult. On the basis of end user, global obsessive compulsive disorder (OCD) drugs market is segmented into hospitals, speciality clinics, home healthcare, others. On the basis of distribution channel, global obsessive compulsive disorder (OCD) drugs market is segmented into hospital pharmacy, retail pharmacy, online pharmacy, others. On the basis of regions- North America, Europe, Asia-Pacific, South America, Middle East and Africa- Industry Trends & Forecast to 2028     

To know more about the study

Key Pointers Covered in Global Obsessive Compulsive Disorder (OCD) Drugs Market Trends and Forecast to 2028

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries
  • Market value and over view of obsessive compulsive disorder (OCD) drugs market
  • Company profiling of top eight players of obsessive compulsive disorder (OCD) drugs market

Key Market Competitors Covered in the Report

  • Sun pharmaceuticals industry Ltd.
  • H.Lunderbeck A/S
  • Teva pharmaceuticals USA. Inc (a subsidiary of Teva Pharmaceuticals Industries Ltd.)
  •  Eli Lilly and company
  •  Apotex Inc.
  • Viatris Inc.
  • Lannett
  • GlaxoSmithKline Plc.
  • Alvogen
  •  Pfizer Inc.
  • Amneal Pharmaceuticals LLC.
  • Dr. Reddy’s Laboratories Ltd.
  • Aurobindo Pharma USA (a subsidiary of Aurobindo Pharma)
  • Abbott
  • Par Pharmaceuticals
  • Sebela Pharmaceuticals
  • Mallinckrodt
  • Lupin
  • Zydus pharmaceutical USA, Inc. (a subsidiary of Zydus Cadila)
  •  Wockhardt

Above are the key players covered in the report, to know about more and exhaustive list of submental fat treatment companies’, contact us

Research Methodology: Global Analytical Laboratory Services Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Healthcare Professionals, Research Laboratories,
  • Supply Side: Manufactures, Service Providers, CRO's

Related Reports

Browse in Healthcare Category Related Reports@